Breakthrough in protein degradation technology unveils a molecular 'finger' that can precisely target specific proteins for destruction, opening doors to revolutionary treatments.
Exploring how SCF E3 ubiquitin ligases function in cancer and the therapeutic strategies targeting these molecular complexes.
Exploring how F-box proteins drive cancer drug resistance through ubiquitin-proteasome system manipulation and potential therapeutic strategies.